Medication info
Teneglo M Sustained Release Tablet 20/1000 mg

Teneglo M Sustained Release Tablet 20/1000 mg

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›26mg / 1 tabletMetformin Hydrochloride›1000mg / 1 tablet
Manufacturer / importer
Ilhwa Co., Ltd.
Appearance
Pink oval-shaped sustained-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202202262 · Approved 2022.05.25 · Insurance code 640904310

Summary

Main use
Improvement of blood glucose control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablets once daily. Patients taking 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's existing dose of metformin. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be started at the patient's existing doses of teneligliptin and metformin. When converting from immediate-release to extended-release metformin, glycemic control should be closely monitored and dose adjustments made as appropriate. When used in combination with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching from other blood glucose-lowering agents. Because changes may affect glycemic control, any changes in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain the extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Ingredients

Manufacturer
Ilhwa Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in patients with type 2 diabetes mellitus

View approved original text

This medication is used in patients with type 2 diabetes where the combination treatment of Teneligliptin and Metformin is appropriate, to improve blood sugar control alongside dietary and exercise regimens.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablets once daily. Patients taking 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's existing dose of metformin. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be started at the patient's existing doses of teneligliptin and metformin. When converting from immediate-release to extended-release metformin, glycemic control should be closely monitored and dose adjustments made as appropriate. When used in combination with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching from other blood glucose-lowering agents. Because changes may affect glycemic control, any changes in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain the extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Precautions

This medication is used to treat diabetes and may cause a rare complication known as severe lactic acidosis, therefore caution is required. Patients with moderate to severe renal impairment or those with heart failure or liver dysfunction should not use this medication. This medication should be temporarily discontinued before radiological examinations and should be resumed only after confirming normal kidney function after the examination. Pregnant women or women who may become pregnant are advised not to take this medication. When used in combination with other diabetes medications, there is a risk of hypoglycemia, so blood sugar levels should be monitored closely. If symptoms such as sudden abdominal pain, vomiting, or shortness of breath occur during treatment, consult a doctor immediately. Elderly patients are at a higher risk of renal function decline, and regular kidney function tests and dosage adjustments are necessary. Alcohol consumption may increase the risk of lactic acidosis and should be avoided. Regular blood tests are necessary as vitamin B12 levels may decrease, and appropriate measures should be taken if abnormalities are found. Patients scheduled for surgery should discontinue this medication 48 hours prior and resume only after confirming normal kidney function. During treatment, patients should fully understand the symptoms of hypoglycemia and responses to it, and should exercise caution when driving or performing hazardous tasks. If skin blisters or rashes occur during treatment, inform a doctor immediately, and consider discontinuing the medication if severe joint pain occurs. This medication may interact with certain drugs, so inform healthcare providers if taking other medications. It is generally not recommended for pediatric patients as safety and efficacy have not been established.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • hypoglycemia
  • constipation
  • intestinal obstruction
  • liver dysfunction
  • interstitial pneumonia
  • bullous pemphigoid
  • acute pancreatitis
  • dizziness
Show 133 more
  • abdominal distension
  • abdominal discomfort
  • nausea
  • abdominal pain
  • bloating
  • stomatitis
  • stomach polyps
  • colon polyps
  • duodenal ulcer
  • gastroesophageal reflux disease
  • diarrhea
  • decreased appetite
  • increased amylase
  • increased lipase
  • elevated AST (GOT)
  • elevated ALT (GPT)
  • elevated GGT
  • elevated ALP
  • proteinuria
  • ketonuria
  • potential hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • elevated CK (CPK)
  • increased serum potassium concentration
  • fatigue
  • allergic rhinitis
  • elevated serum uric acid
  • peripheral edema
  • herpes zoster
  • limb pain
  • upper abdominal pain
  • gastritis
  • upper respiratory infection
  • tremors
  • headache
  • weakness
  • hunger
  • fatigue
  • facial edema
  • dyspepsia
  • nausea
  • viral upper respiratory infection
  • rhinitis
  • cold sweat
  • diabetic retinopathy
  • visual impairment
  • cough
  • pulmonary congestion
  • shortness of breath
  • drug overdose
  • benign prostatic hyperplasia
  • headache
  • diarrhea
  • chronic gastritis
  • irritable bowel syndrome
  • viral upper respiratory infection
  • fatigue
  • cerebral infarction
  • hyperglycemia
  • liver biopsy
  • decrease in neutrophils
  • blood sugar abnormalities
  • increased blood sugar
  • increased blood pressure
  • hepatic coma
  • lumbar spinal canal stenosis
  • intravertebral disc protrusion
  • intravertebral disc disorder
  • spinal ligament ossification
  • spinal foraminal stenosis
  • rotator cuff syndrome
  • bladder mass
  • ureterolithiasis
  • urinary stones
  • coronary artery disease
  • unstable angina
  • gastroesophageal reflux disease
  • gastric polyps
  • gastritis
  • bile duct obstruction
  • chronic cholecystitis
  • soft tissue infection
  • pneumonia
  • cataract
  • depression
  • iliac artery stenosis
  • dizziness
  • benign prostatic hyperplasia
  • knee surgery
  • vomiting
  • abdominal pain
  • gastrointestinal motility disorder
  • decreased gastrointestinal motility
  • enteritis
  • toothache
  • anal-rectal discomfort
  • acquired mixed hyperlipidemia
  • hypertriglyceridemia
  • vitamin D deficiency
  • abnormal weight gain
  • shortness of breath
  • exertional dyspnea
  • atelectasis
  • nasal bleeding
  • chest discomfort
  • fever
  • chills
  • systemic edema
  • injection site inflammation
  • ovarian cyst
  • vulvar pruritus
  • menopausal symptoms
  • toxic hepatitis
  • non-alcoholic fatty liver disease
  • alcoholic liver disease
  • eyelid damage
  • ligament sprain
  • lip injury
  • contusion
  • urticaria
  • glaucoma
  • blurred vision
  • age-related macular degeneration
  • hyperthyroidism
  • hyperparathyroidism
  • otalgia
  • iron deficiency anemia
  • food allergy
  • pressure ulcer

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to prevent exposure to air or moisture. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature to preserve the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

Pink oval-shaped sustained-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.